NCT00069940 Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor Status COMPLETED Phase PHASE1
NCT00068770 Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT Status TERMINATED Phase PHASE2
NCT00068250 Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00064363 Talampanel in Treating Patients With Recurrent High-Grade Glioma Status COMPLETED Phase PHASE2
NCT00058370 Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma Status COMPLETED Phase NA
NCT00058123 Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma Status COMPLETED Phase PHASE2
NCT00054496 Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme Status UNKNOWN Phase PHASE2
NCT00053872 Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma Status UNKNOWN Phase PHASE3
NCT00053183 Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT00053118 Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer Status COMPLETED Phase PHASE1
NCT00053040 Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas Status WITHDRAWN Phase PHASE1/PHASE2
NCT00052715 Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status TERMINATED Phase PHASE2
NCT00052624 Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma Status UNKNOWN Phase PHASE1
NCT00052455 Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE3
NCT00052286 Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer Status COMPLETED Phase NA
NCT00049361 Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases Status COMPLETED Phase PHASE2
NCT00049023 Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00047294 Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00047281 Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma Status COMPLETED Phase PHASE2